231 related articles for article (PubMed ID: 20578830)
1. Positive progress in immunoPET--not just a coincidence.
McCabe KE; Wu AM
Cancer Biother Radiopharm; 2010 Jun; 25(3):253-61. PubMed ID: 20578830
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
3. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
Kumar K; Ghosh A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
[TBL] [Abstract][Full Text] [Related]
4. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
5. Copper-64-immunoPET imaging: bench to bedside.
Natarajan A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):356-363. PubMed ID: 33045821
[TBL] [Abstract][Full Text] [Related]
6. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.
Verel I; Visser GW; Boerman OC; van Eerd JE; Finn R; Boellaard R; Vosjan MJ; Stigter-van Walsum M; Snow GB; van Dongen GA
Cancer Biother Radiopharm; 2003 Aug; 18(4):655-61. PubMed ID: 14503961
[TBL] [Abstract][Full Text] [Related]
7. Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications.
Fu R; Carroll L; Yahioglu G; Aboagye EO; Miller PW
ChemMedChem; 2018 Dec; 13(23):2466-2478. PubMed ID: 30246488
[TBL] [Abstract][Full Text] [Related]
8.
Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
[TBL] [Abstract][Full Text] [Related]
9. ImmunoPET of Malignant and Normal B Cells with
Zettlitz KA; Tavaré R; Knowles SM; Steward KK; Timmerman JM; Wu AM
Clin Cancer Res; 2017 Dec; 23(23):7242-7252. PubMed ID: 28928164
[No Abstract] [Full Text] [Related]
10. Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology.
Knowles SM; Wu AM
J Clin Oncol; 2012 Nov; 30(31):3884-92. PubMed ID: 22987087
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.
Azhdarinia A; Voss J; Ghosh SC; Simien JA; Hernandez Vargas S; Cui J; Yu WA; Liu Q; Carmon KS
Mol Pharm; 2018 Jun; 15(6):2448-2454. PubMed ID: 29718672
[TBL] [Abstract][Full Text] [Related]
12. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET.
Terwisscha van Scheltinga AG; Ogasawara A; Pacheco G; Vanderbilt AN; Tinianow JN; Gupta N; Li D; Firestein R; Marik J; Scales SJ; Williams SP
Mol Cancer Ther; 2017 Jan; 16(1):134-142. PubMed ID: 27760836
[TBL] [Abstract][Full Text] [Related]
14. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.
Li K; Tavaré R; Zettlitz KA; Mumenthaler SM; Mallick P; Zhou Y; Marks JD; Wu AM
Mol Cancer Ther; 2014 Nov; 13(11):2607-17. PubMed ID: 25143449
[TBL] [Abstract][Full Text] [Related]
15.
McKnight BN; Viola-Villegas NT
J Labelled Comp Radiopharm; 2018 Jul; 61(9):727-738. PubMed ID: 29341222
[TBL] [Abstract][Full Text] [Related]
16. Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging.
Pecking AP; Bellet D; Alberini JL
Clin Exp Metastasis; 2012 Oct; 29(7):847-52. PubMed ID: 22760521
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and
Vivier D; Fung K; Rodriguez C; Adumeau P; Ulaner GA; Lewis JS; Sharma SK; Zeglis BM
Theranostics; 2020; 10(4):1746-1757. PubMed ID: 32042334
[No Abstract] [Full Text] [Related]
18. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
19. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody.
Robinson MK; Doss M; Shaller C; Narayanan D; Marks JD; Adler LP; González Trotter DE; Adams GP
Cancer Res; 2005 Feb; 65(4):1471-8. PubMed ID: 15735035
[TBL] [Abstract][Full Text] [Related]
20. The development of copper radiopharmaceuticals for imaging and therapy.
Shokeen M; Wadas TJ
Med Chem; 2011 Sep; 7(5):413-29. PubMed ID: 21711219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]